20939-17-7 Usage
Type of Compound
Small molecule inhibitor
Target Enzyme
Glycogen synthase kinase-3 (GSK-3)
Enzyme Function
Regulation of cellular processes such as metabolism, gene expression, and apoptosis
Potential Therapeutic Applications
Neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) and various forms of cancer
Mechanism of Action
Inhibition of GSK-3 and modulation of various signaling pathways
Current Status
Promising candidate for further research and development as a potential therapeutic agent
Preclinical Studies
Shown promise in treating neurodegenerative diseases and cancer
Structure
Contains a thiadiazolidine ring with two dithione groups at positions 3 and 5
Check Digit Verification of cas no
The CAS Registry Mumber 20939-17-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,9,3 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 20939-17:
(7*2)+(6*0)+(5*9)+(4*3)+(3*9)+(2*1)+(1*7)=107
107 % 10 = 7
So 20939-17-7 is a valid CAS Registry Number.
InChI:InChI=1/CHNOS/c2-1-3-4/h4H
20939-17-7Relevant articles and documents
Synthesis of 2-amino-5(6)-(4-aminophenyl)benzimidazole derivatives: II. Reaction of 2-nitro-4-thiocyanatoaniline with 4-nitrochlorobenzene
Pilyugin,Sapozhnikov,Shitov
, p. 979 - 984 (2007/10/03)
The reaction of 2-nitro-4-thiocyanatoaniline with 4-nitrochlorobenzene in aqueous alkaline medium in the presence of phase-transfer catalyst at 95-100°C was studied with a view to obtain 4-amino-3,4′- dinitrodiphenyl sulfide. Optimal conditions for the synthesis and isolation of the product were found.
